REPH Recro Pharma Inc

Recro Pharma Inc is a specialty pharmaceutical company. It develops non-opioid products for treatment of serious acute pain. The Company operates through two business divisions: Acute Care division and contract development and manufacturing division.

$3.87
As of 03/03/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
03/07/2014
31,012,003
866,525
$120,016,452
0.00%
SEC Edgar Online
10-Q
10-K
75629F109
US75629F1093
BJ35BP6

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-4.36
-4.63
1.80
195.04%
-41.36%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy